These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 34670228)

  • 1. Phase I/II Dose-Escalation Trial of 3-Fraction Stereotactic Radiosurgery for Resection Cavities From Large Brain Metastases: Health-related Quality of Life Outcomes.
    Rahimy E; Dudley SA; von Eyben R; Pollom EL; Seiger K; Modlin L; Wynne J; Fujimoto D; Jacobs LR; Chang SD; Gibbs IC; Hancock SL; Adler JR; Li G; Choi CYH; Soltys SG
    Am J Clin Oncol; 2021 Nov; 44(11):588-595. PubMed ID: 34670228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase 1/2 Trial of 5-Fraction Stereotactic Radiosurgery With 5-mm Margins With Concurrent and Adjuvant Temozolomide in Newly Diagnosed Supratentorial Glioblastoma: Health-Related Quality of Life Results.
    Pollom EL; Fujimoto D; Wynne J; Seiger K; Modlin LA; Jacobs LR; Azoulay M; von Eyben R; Tupper L; Gibbs IC; Hancock SL; Li G; Chang SD; Adler JR; Harsh GR; Harraher C; Nagpal S; Thomas RP; Recht LD; Choi CYH; Soltys SG
    Int J Radiat Oncol Biol Phys; 2017 May; 98(1):123-130. PubMed ID: 28586949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of quality of life and survival following Gamma Knife surgery for lung cancer brain metastases: a prospective study.
    Bragstad S; Flatebø M; Natvig GK; Eide GE; Skeie GO; Behbahani M; Pedersen PH; Enger PØ; Skeie BS
    J Neurosurg; 2018 Jul; 129(1):71-83. PubMed ID: 28820304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quality of life in patients with brain metastases using the EORTC QLQ-BN20+2 and QLQ-C15-PAL.
    Caissie A; Nguyen J; Chen E; Zhang L; Sahgal A; Clemons M; Kerba M; Arnalot PF; Danjoux C; Tsao M; Barnes E; Holden L; Danielson B; Chow E
    Int J Radiat Oncol Biol Phys; 2012 Jul; 83(4):1238-45. PubMed ID: 22172909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quality of life is maintained using Gamma Knife radiosurgery: a prospective study of a brain metastases patient cohort.
    Skeie BS; Eide GE; Flatebø M; Heggdal JI; Larsen E; Bragstad S; Pedersen PH; Enger PØ
    J Neurosurg; 2017 Mar; 126(3):708-725. PubMed ID: 27058206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quality of life outcomes for brain metastasis patients treated with stereotactic radiosurgery: pre-procedural predictive factors from a prospective national registry.
    Sheehan JP; Grills I; Chiang VL; Dong H; Berg A; Warnick RE; Kondziolka D; Kavanagh B
    J Neurosurg; 2019 Dec; 131(6):1848-1854. PubMed ID: 30579284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quality-of-life trajectories after stereotactic radiosurgery for brain metastases.
    Bunevicius A; Lavezzo K; Shabo L; McClure J; Sheehan JP
    J Neurosurg; 2021 Jun; 134(6):1791-1799. PubMed ID: 32650308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Whole brain radiotherapy versus stereotactic radiosurgery for 4-10 brain metastases: a phase III randomised multicentre trial.
    Zindler JD; Bruynzeel AME; Eekers DBP; Hurkmans CW; Swinnen A; Lambin P
    BMC Cancer; 2017 Jul; 17(1):500. PubMed ID: 28743240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Health-related quality of life after stereotactic radiosurgery in patients with brain metastases.
    Albers EAC; de Ligt KM; van de Poll-Franse LV; Compter A; de Ruiter MB; Schagen SB
    Support Care Cancer; 2023 Nov; 31(12):720. PubMed ID: 38008876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repeat stereotactic radiosurgery as salvage therapy for locally recurrent brain metastases previously treated with radiosurgery.
    McKay WH; McTyre ER; Okoukoni C; Alphonse-Sullivan NK; Ruiz J; Munley MT; Qasem S; Lo HW; Xing F; Laxton AW; Tatter SB; Watabe K; Chan MD
    J Neurosurg; 2017 Jul; 127(1):148-156. PubMed ID: 27494815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early Gamma Knife stereotactic radiosurgery to the tumor bed of resected brain metastasis for improved local control.
    Iorio-Morin C; Masson-Côté L; Ezahr Y; Blanchard J; Ebacher A; Mathieu D
    J Neurosurg; 2014 Dec; 121 Suppl():69-74. PubMed ID: 25434939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurocognitive evaluation of brain metastases patients treated with post-resection stereotactic radiosurgery: a prospective single arm clinical trial.
    Berger A; Strauss I; Ben Moshe S; Corn BW; Limon D; Shtraus N; Shahar T; Kanner AA
    J Neurooncol; 2018 Nov; 140(2):307-315. PubMed ID: 30078070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quality of life in patients with limited (1-3) brain metastases undergoing stereotactic or whole brain radiotherapy : A prospective study of the DEGRO QoL working group.
    Steinmann D; Vordermark D; Gerstenberg W; Aschoff R; Gharbi N; Müller A; Schäfer C; Theodorou M; Wypior HJ; Geinitz H;
    Strahlenther Onkol; 2020 Jan; 196(1):48-57. PubMed ID: 31418046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stereotactic radiosurgery to the resection bed for intracranial metastases and risk of leptomeningeal carcinomatosis.
    Ojerholm E; Lee JY; Thawani JP; Miller D; O'Rourke DM; Dorsey JF; Geiger GA; Nagda S; Kolker JD; Lustig RA; Alonso-Basanta M
    J Neurosurg; 2014 Dec; 121 Suppl():75-83. PubMed ID: 25434940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of 2-staged stereotactic radiosurgery for treatment of brain metastases ≥ 2 cm.
    Angelov L; Mohammadi AM; Bennett EE; Abbassy M; Elson P; Chao ST; Montgomery JS; Habboub G; Vogelbaum MA; Suh JH; Murphy ES; Ahluwalia MS; Nagel SJ; Barnett GH
    J Neurosurg; 2018 Aug; 129(2):366-382. PubMed ID: 28937324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential role for LINAC-based stereotactic radiosurgery for the treatment of 5 or more radioresistant melanoma brain metastases.
    Frakes JM; Figura NB; Ahmed KA; Juan TH; Patel N; Latifi K; Sarangkasiri S; Strom TJ; Chinnaiyan P; Rao NG; Etame AB
    J Neurosurg; 2015 Nov; 123(5):1261-7. PubMed ID: 26140482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical outcomes of gastrointestinal brain metastases treated with radiotherapy.
    Sanghvi SM; Lischalk JW; Cai L; Collins S; Nair M; Collins B; Unger K
    Radiat Oncol; 2017 Feb; 12(1):43. PubMed ID: 28245881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postoperative stereotactic radiosurgery compared with whole brain radiotherapy for resected metastatic brain disease (NCCTG N107C/CEC·3): a multicentre, randomised, controlled, phase 3 trial.
    Brown PD; Ballman KV; Cerhan JH; Anderson SK; Carrero XW; Whitton AC; Greenspoon J; Parney IF; Laack NNI; Ashman JB; Bahary JP; Hadjipanayis CG; Urbanic JJ; Barker FG; Farace E; Khuntia D; Giannini C; Buckner JC; Galanis E; Roberge D
    Lancet Oncol; 2017 Aug; 18(8):1049-1060. PubMed ID: 28687377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A phase 2 trial of stereotactic radiosurgery boost after surgical resection for brain metastases.
    Brennan C; Yang TJ; Hilden P; Zhang Z; Chan K; Yamada Y; Chan TA; Lymberis SC; Narayana A; Tabar V; Gutin PH; Ballangrud Å; Lis E; Beal K
    Int J Radiat Oncol Biol Phys; 2014 Jan; 88(1):130-6. PubMed ID: 24331659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Three or More Courses of Stereotactic Radiosurgery for Patients with Multiply Recurrent Brain Metastases.
    Kotecha R; Damico N; Miller JA; Suh JH; Murphy ES; Reddy CA; Barnett GH; Vogelbaum MA; Angelov L; Mohammadi AM; Chao ST
    Neurosurgery; 2017 Jun; 80(6):871-879. PubMed ID: 28327948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.